

| カタログ番号 | HM810013 | ||||
|---|---|---|---|---|---|
| 種反応性 | Human | ||||
| アプリケーション | ELISA | ||||
| 宿主種 | Mouse | ||||
| クローン性 | Monoclonal | ||||
| アイソタイプ | IgG2a, kappa | ||||
| クローンID | SAA1568 | ||||
| ターゲット | HLA-Cw, HLA-C, Human leukocyte antigen C, HLAC, HLA class I histocompatibility antigen, C alpha chain | ||||
| エンドトキシンレベル | Please contact with the lab for this information. | ||||
| 純度 | >95% as determined by SDS-PAGE. | ||||
| 精製 | Protein A/G purified from cell culture supernatant. | ||||
| アクセッション番号 | P10321 | ||||
| RRID | Anti-Human HLA-C Antibody (SAA1568) (abinScience Cat# HM810013, RRID:AB_3727329) |
||||
| 形態 | Liquid | ||||
| 保存バッファー | 0.01M PBS pH 7.4 データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。 |
||||
| 製品使用情報 |
| ||||
| 安定性と保存 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. | ||||
| 背景 | HLA class I histocompatibility antigen, C alpha chain (HLA-C) is a ~40 kDa protein. Antigen-presenting major histocompatibility complex class I (MHCI) molecule with an important role in reproduction and antiviral immunity. In complex with B2M/beta 2 microglobulin displays a restricted repertoire of self and viral peptides and acts as a dominant ligand for inhibitory and activating killer immunoglobulin receptors (KIRs) expressed on NK cells. In an allogeneic setting, such as during pregnancy, mediates interaction of extravillous trophoblasts with KIR on uterine NK cells and regulate trophoblast invasion necessary for placentation and overall fetal growth. During viral infection, may present viral peptides with low affinity for KIRs, impeding KIR-mediated inhibition through peptide antagonism and favoring lysis of infected cells. Presents a restricted repertoire of viral peptides on antigen-presenting cells for recognition by alpha-beta T cell receptor (TCR) on HLA-C-restricted CD8-positive T cells, guiding antigen-specific T cell immune response to eliminate infected cells, particularly in chronic viral infection settings such as HIV-1 or CMV infection. 1. Addo, MM. et al. (2001) Proceedings of the National Academy of Sciences of the United States of America 98, 1781-6. PMID: 11172028 2. Makadzange, AT. et al. (2010) European journal of immunology 40, 1036-41. PMID: 20104487 3. Fadda, L. et al. (2010) Proceedings of the National Academy of Sciences of the United States of America 107, 10160-5. PMID: 20439706 4. Hiby, SE. et al. (2010) The Journal of clinical investigation 120, 4102-10. PMID: 20972337 5. Xiong, S. et al. (2013) The Journal of clinical investigation 123, 4264-72. PMID: 24091323 6. Kaur, G. et al. (2017) Nature communications 8, 15924. PMID: 28649982 7. Hosie, L. et al. (2017) Frontiers in immunology 8, 1776. PMID: 29312307 8. Stewart, CA. et al. (2005) Proceedings of the National Academy of Sciences of the United States of America 102, 13224-9. PMID: 16141329 | ||||
| 注意事項 | For research use only. |

SDS-PAGE for Anti-Human HLA-C Antibody (SAA1568)


+86-027-65523339
中国武漢市深敦寺路666号C棟、武漢、430206

中文
English
한국어
日本語
Español
Français
Русский